Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029289 · ClinicalTrials.gov registry record · Phase 1
Effects of Lutein in Retinitis Pigmentosa
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00029289 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH).
The verdict
NCT00029289, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Phase I/II double-masked, randomized, placebo-controlled, cross-over trial to determine effects of lutein on vision in retinitis pigmentosa, including safety and effective dosage assessment
Interventions
- DRUG Lutein (10 or 30 mg/day) capsules
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-04 |
| Est. Completion | 2002-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029289
The ClinicalTrials.gov registry entry for NCT00029289 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lutein (10 or 30 mg/day) capsules is the first listed.
NCT00029289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029289 about?
NCT00029289 is a clinical study titled "Effects of Lutein in Retinitis Pigmentosa". Phase I/II double-masked, randomized, placebo-controlled, cross-over trial to determine effects of lutein on vision in retinitis pigmentosa, including safety and effective dosage assessment
What is the current status of trial NCT00029289?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-04. Estimated completion is 2002-10.
What interventions are being tested in trial NCT00029289?
The interventions under investigation include: Lutein (10 or 30 mg/day) capsules (DRUG).
Who is sponsoring clinical trial NCT00029289?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.